Sectra's year-end report 2010/2011: Sectra grows and invests for the future

Sectra's year-end report 2010/2011:

Sectra grows and invests for the future

The IT and medical-technology company Sectra's net sales rose 7.4% to
SEK 910.9 million (848.4) for the 2010/2011 fiscal year, due to
increased transactions with existing customers and breakthroughs in new
countries. The most significant milestone for the fiscal year was
approval of the Sectra MicroDose Mammography system by the US Food and
Drug Administration (FDA).

“We will initially market and sell Sectra MicroDose Mammography in the
US through our own sales organization. We then look forward to
collaborating with one or more partners who can help us conquer the US
market,” says Jan-Olof Brüer, President and CEO of Sectra AB.

Operating profit for the fiscal year amounted to SEK 8.2 million (34.2),
corresponding to an operating margin of 0.9% (4.0). After net financial
items, an operating loss of SEK 8.1 million (profit: 23.5) was reported.
Currency fluctuations had a negative effect of SEK 18.3 million (neg:
9.3) on the Group's financial items.

“The Mammography product division grew 35% in 2010/2011 but our earnings
are still impacted by the product division's loss and the strong Swedish
currency,” says Jan-Olof Brüer. “In an effort to maintain and strengthen
our competitiveness with a relatively highly valued Swedish currency, we
are now working to reduce our production, installation and upgrading
costs.”

In the fourth quarter of the fiscal year, the Sectra Group's net sales
were SEK 228.2 million (255.4). Operating profit amounted to SEK 6.5
million (20.2), corresponding to an operating margin of 2.8% (7.9).
Operating profit after net financial items was SEK 1.7 million (16.6)
for the quarter.

Sectra's strong cash balance and balance sheet enable the company to
continue investing for the future. The 2010/2011 fiscal year was
characterized by ongoing work to upgrade customers to the next
generation of Sectra PACS, breakthroughs in the radiology IT market in
Saudi Arabia and mammography market in Canada, regulatory approvals of
Sectra's mammography product in new countries and the introduction of
new products such as the visualization table. Sectra has also signed a
framework agreement with the European Council for secure telephony and
launched a new model of the secure mobile telephone, Tiger. The new
products and regulatory approvals broaden Sectra's market and strengthen
the company's potential for achieving the Group's earnings and growth
targets.

“Our growing customer base generates continuous new transactions, and
long-term customer relations are our key success factor. We are
constantly expanding our offering with new products and services that
make life easier for our customers and contribute to our expansion,”
says Jan-Olof Brüer.

The year-end report can be downloaded from Sectras
website (http://www.sectra.com).

The information in this press release is such that Sectra AB (publ) is
obligated to disclose in accordance with the Swedish Securities and
Clearing Operations Act. The information was submitted for publication
on May 24, 2011, at 8:00 a.m. (CET).

For further information, please contact:

Dr. Jan-Olof Brüer, CEO and President Sectra AB, tel 46 13 23 52 09